Glutathione in metastases: From mechanisms to clinical applications

Critical Reviews in Clinical Laboratory Sciences

Volumn 53, Issue 4, 2016, Pages 253-267

  Estrela, José M ^a,b   Ortega, Angel ^b   Mena, Salvador ^b   Sirerol, J Antoni ^b   Obrador, Elena ^a  

^a Faculty of Medicine and Odontology   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

cancer; Glutathione; metastases; neuroendocrine regulation; oncotherapy; stress

Indexed keywords

GLUTATHIONE;

ADAPTATION; CANCER CELL; CANCER GROWTH; CELL SURVIVAL; CYTOLOGY; GENE CONTROL; HUMAN; INTRACELLULAR SIGNALING; METASTASIS; NITROSATIVE STRESS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; METABOLISM; MOUSE; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; GLUTATHIONE; HUMANS; MICE; NEOPLASM METASTASIS; NEOPLASMS;

EID: 84958768415     PISSN: 10408363     EISSN: 1549781X     Source Type: Journal    
DOI: 10.3109/10408363.2015.1136259     Document Type: Review

References (204)

1. H.Sies Biochemistry of oxidative stress. Angew Chem Int Ed Eng 1986;25:1058–71
2. H.Sies Oxidative stress: a concept in redox biology and medicine. Redox Biol 2015;4:180–3
3. I.S.Harris, A.E.Treloar, S.Inoue,. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 2015;27:211–22
4. E.Piskounova, M.Agathocleous, M.M.Murphy,. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 2015;527:186–91
5. A.Meister, M.E.Anderson Glutathione. Annu Rev Biochem 1983;52:711–60
6. H.Sies Glutathione and its role in cellular functions. Free Radic Biol Med 1999;27:916–21
7. J.M.Estrela, A.Ortega, E.Obrador Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 2006;43:143–81
8. H.J.Forman, H.Zhang, A.Rinna Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med 2009;30:1–12
9. J.B.Mitchell, A.Russo The role of glutathione in radiation and drug induced cytotoxicity. Br J Cancer Suppl 1987;8:96–104
10. A.Meister Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol Ther 1991;51:155–94
11. P.Calvert, K.S.Yao, T.C.Hamilton, P.J.O'Dwyer Clinical studies of reversal of drug resistance based on glutathione. Chem Biol Interact 1998;111112:213–24
12. E.Obrador, J.Carretero, J.M.Esteve,. Glutamine potentiates TNF-alpha-induced tumor cytotoxicity. Free Radic Biol Med 2001;31:642–50
13. G.Pani, T.Galeotti, P.Chiarugi Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev 2010;29:351–78
14. M.P.Gamcsik, M.S.Kasibhatla, S.D.Teeter, O.M.Colvin Glutathione levels in human tumors. Biomarkers 2012;17:671–91
15. N.Traverso, R.Ricciarelli, M.Nitti,. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev 2013;2013:972913
16. K.Aquilano, S.Baldelli, M.R.Ciriolo Glutathione: new roles in redox signaling for an old antioxidant. Front Pharmacol 2014;5:196
17. D.P.Jones Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol 2002;348:93–112
18. N.Srivastava, R.K.Kollipara, D.K.Singh,. Inhibition of cancer cell proliferation by PPARgamma is mediated by a metabolic switch that increases reactive oxygen species levels. Cell Metab 2014;20:650–61
19. K.Irani, Y.Xia, J.L.Zweier,. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997;275:1649–52
20. C.Polytarchou, M.Hatziapostolou, E.Papadimitriou Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J Biol Chem 2005;280:40428–35
21. H.E.Marshall, K.Merchant, J.S.Stamler Nitrosation and oxidation in the regulation of gene expression. FASEB J 2000;14:1889–900
22. H.Okada, T.W.Mak Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 2004;4:592–603
23. S.L.Payne, B.Fogelgren, A.R.Hess,. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res 2005;65:11429–36
24. G.Lamonte, X.Tang, J.L.Chen,. Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress. Cancer Metab 2013;1:23
25. J.Lu, M.Tan, Q.Cai The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett 2015;356:156–64
26. J.W.Erickson, R.A.Cerione Glutaminase: a hot spot for regulation of cancer cell metabolism? Oncotarget 2010;1:734–40
27. R.A.Gatenby, R.J.Gillies Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4:891–9
28. H.Sies, C.Gerstenecker, H.Menzel, L.Flohe Oxidation in the NADP system and release of GSSG from hemoglobin-free perfused rat liver during peroxidatic oxidation of glutathione by hydroperoxides. FEBS Lett 1972;27:171–5
29. D.A.Dickinson, H.J.Forman Glutathione in defense and signaling: lessons from a small thiol. Ann N Y Acad Sci 2002;973:488–504
30. N.Ballatori, S.M.Krance, R.Marchan, C.L.Hammond Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology. Mol Aspects Med 2009;30:13–28
31. G.Jedlitschky, I.Leier, U.Buchholz,. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 1994;54:4833–6
32. M.Muller, C.Meijer, G.J.Zaman,. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 1994;91:13033–7
33. I.Leier, G.Jedlitschky, U.Buchholz,. ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem J 1996;314:433–7
34. D.Keppler, I.Leier, G.Jedlitschky Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 1997;378:787–91
35. N.Ballatori, S.M.Krance, S.Notenboom,. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 2009;390:191–214
36. L.P.Yap, H.Sancheti, M.D.Ybanez,. Determination of GSH, GSSG, and GSNO using HPLC with electrochemical detection. Meth Enzymol 2010;473:137–47
37. S.C.Lu Glutathione synthesis. Biochim Biophys Acta 2013;1830:3143–53
38. M.H.Hanigan Gamma-glutamyl transpeptidase: redox regulation and drug resistance. Adv Cancer Res 2014;122:103–41
39. E.Obrador, J.Carretero, A.Ortega,. gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver. Hepatology 2002;35:74–81
40. S.M.Deneke, B.L.Fanburg Regulation of cellular glutathione. Am J Physiol 1989;257:L163–73
41. N.P.Curthoys, R.P.Hughey Characterization and physiological function of rat renal gamma-glutamyltranspeptidase. Enzyme 1979;24:383–403
42. M.H.Hanigan, W.A.Ricketts Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase. Biochemistry 1993;32:6302–6
43. A.Meister Selective modification of glutathione metabolism. Science 1983;220:472–7
44. S.N.Hochwald, L.E.Harrison, D.M.Rose,. gamma-Glutamyl transpeptidase mediation of tumor glutathione utilization in vivo. J Natl Cancer Inst 1996;88:193–7
45. A.L.Ortega, S.Mena, J.M.Estrela Glutathione in cancer cell death. Cancers (Basel) 2011;3:1285–310
46. Y.Liu, A.S.Hyde, M.A.Simpson, J.J.Barycki Emerging regulatory paradigms in glutathione metabolism. Adv Cancer Res 2014;122:69–101
47. M.M.Gottesman, T.Fojo, S.E.Bates Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48–58
48. C.A.Klein Selection and adaptation during metastatic cancer progression. Nature 2013;501:365–72
49. P.L.Bedard, A.R.Hansen, M.J.Ratain, L.L.Siu Tumour heterogeneity in the clinic. Nature 2013;501:355–64
50. F.Q.Schafer, G.R.Buettner Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001;30:1191–212
51. H.A.Krebs, R.L.Veech Equilibrium relations between pyridine nucleotides and adenine nucleotides and their roles in the regulation of metabolic processes. Adv Enzyme Regul 1969;7:397–413
52. T.Bucher, B.Brauser, A.Conze,. State of oxidation-reduction and state of binding in the cytosolic NADH-system as disclosed by equilibration with extracellular lactate-pyruvate in hemoglobin-free perfused rat liver. Eur J Biochem 1972;27:301–17
53. H.Sies, R.Brigelius, H.Wefers,. Cellular redox changes and response to drugs and toxic agents. Fundam Appl Toxicol 1983;3:200–8
54. P.Schonfeld, R.Bohnensack, G.Bohme, W.Kunz Influence of the beta-hydroxybutyrate/acetoacetate ratio on the redox states of mitochondrial NAD(P) and cytochrome c systems, extramitochondrial ATP/ADP ratio and the respiration of isolated liver mitochondria in the resting state. Biomed Biochim Acta 1983;42:3–13
55. D.P.Jones, H.Sies The Redox Code. Antioxid Redox Signal 2015;23:734–46
56. J.F.Allen Control of gene expression by redox potential and the requirement for chloroplast and mitochondrial genomes. J Theor Biol 1993;165:609–31
57. D.P.Jones Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 2008;295:C849–68
58. S.E.Pedersen, E.M.Ross Functional activation of beta-adrenergic receptors by thiols in the presence or absence of agonists. J Biol Chem 1985;260:14150–7
59. F.Tewes, G.F.Bol, R.Brigelius-Flohe Thiol modulation inhibits the interleukin (IL)-1-mediated activation of an IL-1 receptor-associated protein kinase and NF-kappa B. Eur J Immunol 1997;27:3015–21
60. S.R.Lee, K.S.Kwon, S.R.Kim, S.G.Rhee Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 1998;273:15366–72
61. C.X.Yu, S.Li, A.R.Whorton Redox regulation of PTEN by S-nitrosothiols. Mol Pharmacol 2005;68:847–54
62. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 1993;12:2005–15
63. P.Pognonec, H.Kato, R.G.Roeder The helix-loop-helix/leucine repeat transcription factor USF can be functionally regulated in a redox-dependent manner. J Biol Chem 1992;267:24563–7
64. R.Rainwater, D.Parks, M.E.Anderson,. Role of cysteine residues in regulation of p53 function. Mol Cell Biol 1995;15:3892–903
65. S.G.Ahn, D.J.Thiele Redox regulation of mammalian heat shock factor 1 is essential for Hsp gene activation and protection from stress. Genes Dev 2003;17:516–28
66. M.Ilbert, J.Horst, S.Ahrens,. The redox-switch domain of Hsp33 functions as dual stress sensor. Nat Struct Mol Biol 2007;14:556–63
67. R.Brigelius-Flohe, L.Flohe Basic principles and emerging concepts in the redox control of transcription factors. Antioxid Redox Signal 2011;15:2335–81
68. S.G.Rhee, S.W.Kang, W.Jeong,. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol 2005;17:183–9
69. H.Sies Role of metabolic H2O2 generation: redox signaling and oxidative stress. J Biol Chem 2014;289:8735–41
70. D.Popov Protein S-glutathionylation: from current basics to targeted modifications. Arch Physiol Biochem 2014;120:123–30
71. M.D.Shelton, P.B.Chock, J.J.Mieyal Glutaredoxin: role in reversible protein s-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid Redox Signal 2005;7:348–66
72. A.Holmgren Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid Redox Signal 2000;2:811–20
73. C.H.Lillig, C.Berndt, A.Holmgren Glutaredoxin systems. Biochim Biophys Acta 2008;1780:1304–17
74. S.M.Beer, E.R.Taylor, S.E.Brown,. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant defense. J Biol Chem 2004;279:47939–51
75. T.Nguyen, P.J.Sherratt, C.B.Pickett Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 2003;43:233–60
76. A.C.Wild, H.R.Moinova, R.T.Mulcahy Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem 1999;274:33627–36
77. M.Biswas, J.Y.Chan Role of Nrf1 in antioxidant response element-mediated gene expression and beyond. Toxicol Appl Pharmacol 2010;244:16–20
78. B.Rotblat, G.Melino, R.A.Knight NRF2 and p53: Januses in cancer? Oncotarget 2012;3:1272–83
79. E.Kansanen, S.M.Kuosmanen, H.Leinonen, A.L.Levonen The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol 2013;1:45–9
80. R.Faraonio, P.Vergara, D.Di Marzo,. p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. J Biol Chem 2006;281:39776–84
81. Y.Kalechman, G.Strassmann, M.Albeck, B.Sredni Up-regulation by ammonium trichloro(dioxoethylene-0,0′) tellurate (AS101) of Fas/Apo-1 expression on B16 melanoma cells: implications for the antitumor effects of AS101. J Immunol 1998;161:3536–42
82. P.A.Muller, K.H.Vousden, J.C.Norman p53 and its mutants in tumor cell migration and invasion. J Cell Biol 2011;192:209–18
83. E.Obrador, S.L.Valles, M.Benlloch,. Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: an endocrine system-related mechanism that compromises metastatic cell resistance to vascular endothelium-induced tumor cytotoxicity. PLoS One 2014;9:e96466
84. L.P.Bignold, B.L.Coghlan, H.P.Jersmann Cancer morphology, carcinogenesis and genetic instability: a background. EXS 2006;96:1–24
85. C.Scheel, T.Onder, A.Karnoub, R.A.Weinberg Adaptation versus selection: the origins of metastatic behavior. Cancer Res 2007;67:11476–9
86. A.L.Ortega, S.Mena, J.M.Estrela Oxidative and nitrosative stress in the metastatic microenvironment. Cancers (Basel) 2010;2:274–304
87. G.L.Nicolson Generation of phenotypic diversity and progression in metastatic tumor cells. Cancer Metastasis Rev 1984;3:25–42
88. J.D.Minna, J.M.Kurie, T.Jacks A big step in the study of small cell lung cancer. Cancer Cell 2003;4:163–6
89. H.Peinado, S.Lavotshkin, D.Lyden The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol 2011;21:139–46
90. J.E.Talmadge, S.R.Wolman, I.J.Fidler Evidence for the clonal origin of spontaneous metastases. Science 1982;217:361–3
91. I.J.Fidler, J.E.Talmadge Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Res 1986;46:5167–71
92. H.Fazilaty, M.Gardaneh, T.Bahrami,. Crosstalk between breast cancer stem cells and metastatic niche: emerging molecular metastasis pathway? Tumour Biol 2013;34:2019–30
93. S.Dawood, L.Austin, M.Cristofanilli Cancer stem cells: implications for cancer therapy. Oncology (Williston Park NY) 2014;28:1101–7
94. S.A.Mani, W.Guo, M.J.Liao,. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704–15
95. A.P.Morel, M.Lievre, C.Thomas,. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008;3:e2888
96. K.Naka, T.Muraguchi, T.Hoshii, A.Hirao Regulation of reactive oxygen species and genomic stability in hematopoietic stem cells. Antioxid Redox Signal 2008;10:1883–94
97. M.Diehn, R.W.Cho, N.A.Lobo,. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009;458:780–3
98. W.J.Wu, Y.Zhang, Z.L.Zeng,. β-Phenylethyl isothiocyanate reverses platinum resistance by a GSH-dependent mechanism in cancer cells with epithelial-mesenchymal transition phenotype. Biochem Pharmacol 2013;85:486–96
99. Q.Zhan, C.Wang, S.Ngai Ovarian cancer stem cells: a new target for cancer therapy. Biomed Res Int 2013;2013:916819
100. M.Goto, H.Miwa, K.Suganuma,. Adaptation of leukemia cells to hypoxic condition through switching the energy metabolism or avoiding the oxidative stress. BMC Cancer 2014;14:76
101. J.K.Kim, H.Y.Jeon, H.Kim The molecular mechanisms underlying the therapeutic resistance of cancer stem cells. Arch Pharm Res 2015;38:389–401
102. S.Mena, M.Benlloch, A.Ortega,. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease. Clin Cancer Res 2007;13:2658–66
103. L.A.Diaz, JrR.T.Williams, J.Wu,. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 2012;486:537–40
104. C.E.Meacham, S.J.Morrison Tumour heterogeneity and cancer cell plasticity. Nature 2013;501:328–37
105. A.Bardelli, P.A.Janne The road to resistance: EGFR mutation and cetuximab. Nat Med 2012;18:199–200
106. D.X.Nguyen, P.D.Bos, J.Massague Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009;9:274–84
107. S.Paget The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 1989;8:98–101
108. Y.Husemann, J.B.Geigl, F.Schubert,. Systemic spread is an early step in breast cancer. Cancer Cell 2008;13:58–68
109. T.Guise Examining the metastatic niche: targeting the microenvironment. Semin Oncol 2010;37(Suppl 2):S2–14
110. P.Ordonez-Moran, J.Huelsken Complex metastatic niches: already a target for therapy? Curr Opin Cell Biol 2014;31:29–38
111. J.A.Joyce, J.W.Pollard Microenvironmental regulation of metastasis. Nat Rev Cancer 2009;9:239–52
112. M.S.Sosa, P.Bragado, J.A.Aguirre-Ghiso Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer 2014;14:611–22
113. M.Havard, F.Dautry, T.Tchenio A dormant state modulated by osmotic pressure controls clonogenicity of prostate cancer cells. J Biol Chem 2011;286:44177–86
114. S.Nishikawa, H.Ishii, N.Haraguchi,. Genotoxic therapy stimulates error-prone DNA repair in dormant hepatocellular cancer stem cells. Exp Ther Med 2012;3:959–62
115. Z.Vincent, K.Urakami, K.Maruyama,. CD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile. Genes Cancer 2014;5:250–60
116. R.R.Langley, I.J.Fidler Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 2007;28:297–321
117. S.A.Joosse, T.M.Gorges, K.Pantel Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med 2014;7:1–11
118. A.F.Chambers, A.C.Groom, I.C.MacDonald Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563–72
119. S.Meng, D.Tripathy, E.P.Frenkel,. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 2004;10:8152–62
120. D.Glaves Intravascular death of disseminated cancer cells mediated by superoxide anion. Invas Metastasis 1986;6:101–11
121. L.Bouwens, R.Jacobs, L.Remels, E.Wisse Natural cytotoxicity of rat hepatic natural killer cells and macrophages against a syngeneic colon adenocarcinoma. Cancer Immunol Immunother 1988;27:137–41
122. L.Weiss, U.Nannmark, B.R.Johansson, U.Bagge Lethal deformation of cancer cells in the microcirculation: a potential rate regulator of hematogenous metastasis. Int J Cancer 1992;50:103–7
123. E.Barbera-Guillem, I.Smith, L.Weiss Cancer-cell traffic in the liver. II. Arrest, transit and death of B16F10 and M5076 cells in the sinusoids. Int J Cancer 1993;53:298–301
124. J.Carretero, E.Obrador, J.M.Esteve,. Tumoricidal activity of endothelial cells. Inhibition of endothelial nitric oxide production abrogates tumor cytotoxicity induced by hepatic sinusoidal endothelium in response to B16 melanoma adhesion in vitro. J Biol Chem 2001;276:25775–82
125. A.B.Al-Mehdi, K.Tozawa, A.B.Fisher,. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000;6:100–2
126. M.W.Radomski, D.C.Jenkins, L.Holmes, S.Moncada Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res 1991;51:6073–8
127. P.Gassmann, J.Haier The tumor cell-host organ interface in the early onset of metastatic organ colonisation. Clin Exp Metastasis 2008;25:171–81
128. F.W.Orr, H.H.Wang, R.M.Lafrenie,. Interactions between cancer cells and the endothelium in metastasis. J Pathol 2000;190:310–29
129. R.H.Burdon Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995;18:775–94
130. C.Blanchetot, J.Boonstra The ROS-NOX connection in cancer and angiogenesis. Crit Rev Eukaryot Gene Expr 2008;18:35–45
131. J.T.Hancock The role of redox mechanisms in cell signalling. Mol Biotechnol 2009;43:162–6
132. M.Nishikawa Reactive oxygen species in tumor metastasis. Cancer Lett 2008;266:53–9
133. D.Fukumura, S.Kashiwagi, R.K.Jain The role of nitric oxide in tumour progression. Nat Rev Cancer 2006;6:521–34
134. A.F.Chambers, I.C.MacDonald, E.E.Schmidt,. Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer Metastasis Rev 1995;14:279–301
135. H.Yasuda Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer. Nitric Oxide 2008;19:205–16
136. K.M.Dameron, O.V.Volpert, M.A.Tainsky, N.Bouck Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994;265:1582–4
137. J.Rak, Y.Mitsuhashi, L.Bayko,. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 1995;55:4575–80
138. J.R.Gnarra, S.Zhou, M.J.Merrill,. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci USA 1996;93:10589–94
139. G.Siemeister, K.Weindel, K.Mohrs,. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 1996;56:2299–301
140. D.M.Brizel, G.S.Sibley, L.R.Prosnitz,. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997;38:285–9
141. G.L.Semenza Involvement of hypoxia-inducible factor 1 in human cancer. Intern Med 2002;41:79–83
142. B.Meier, H.H.Radeke, S.Selle,. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem J 1989;263:539–45
143. H.Qiu, F.W.Orr, D.Jensen,. Arrest of B16 melanoma cells in the mouse pulmonary microcirculation induces endothelial nitric oxide synthase-dependent nitric oxide release that is cytotoxic to the tumor cells. Am J Pathol 2003;162:403–12
144. J.M.Jessup, P.Battle, H.Waller,. Reactive nitrogen and oxygen radicals formed during hepatic ischemia-reperfusion kill weakly metastatic colorectal cancer cells. Cancer Res 1999;59:1825–9
145. M.J.Anasagasti, J.J.Martin, L.Mendoza,. Glutathione protects metastatic melanoma cells against oxidative stress in the murine hepatic microvasculature. Hepatology 1998;27:1249–56
146. A.L.Ortega, J.Carretero, E.Obrador,. Tumor cytotoxicity by endothelial cells. Impairment of the mitochondrial system for glutathione uptake in mouse B16 melanoma cells that survive after in vitro interaction with the hepatic sinusoidal endothelium. J Biol Chem 2003;278:13888–97
147. K.Andreassen, B.Mortensen, J.O.Winberg, N.E.Huseby Increased resistance towards oxidative stress accompanies enhancement of metastatic potential obtained by repeated in vivo passage of colon carcinoma cells in syngeneic rats. Clin Exp Metastasis 2002;19:623–9
148. P.Bilbao, M.del Olmo, A.Alonso-Varona,. L2-Oxothiazolidine-4-carboxylate reverses the tumour growth-promoting effect of interleukin-2 and improves the anti-tumour efficacy of biochemotherapy in mice bearing B16 melanoma liver metastases. Melanoma Res 2002;12:17–26
149. Y.P.Yu, G.Yu, G.Tseng,. Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res 2007;67:8043–50
150. G.Kroemer, L.Galluzzi, C.Brenner Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007;87:99–163
151. G.M.Bartoli, H.Sies Reduced and oxidized glutathione efflux from liver. FEBS Lett 1978;86:89–91
152. N.Ballatori, J.F.Rebbeor Roles of MRP2 and oatp1 in hepatocellular export of reduced glutathione. Semin Liver Dis 1998;18:377–87
153. E.Lazar-Molnar, H.Hegyesi, S.Toth, A.Falus Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 2000;12:547–54
154. E.Obrador, M.Benlloch, J.A.Pellicer,. Intertissue flow of glutathione (GSH) as a tumor growth-promoting mechanism: interleukin 6 induces GSH release from hepatocytes in metastatic B16 melanoma-bearing mice. J Biol Chem 2011;286:15716–27
155. B.E.Barton Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes. Expert Opin Ther Targets 2005;9:737–52
156. D.R.Hodge, E.M.Hurt, W.L.Farrar The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005;41:2502–12
157. J.F.Rossi, Z.Y.Lu, M.Jourdan, B.Klein Interleukin-6 as a therapeutic target. Clin Cancer Res 2015;21:1248–57
158. T.Ara, Y.A.Declerck Interleukin-6 in bone metastasis and cancer progression. Eur J Cancer 2010;46:1223–31
159. U.Emmenegger, R.S.Kerbel Cancer: chemotherapy counteracted. Nature 2010;468:637–8
160. M.Moreno-Smith, S.K.Lutgendorf, A.K.Sood Impact of stress on cancer metastasis. Future Oncol 2010;6:1863–81
161. B.Leibowitz, J.Yu Mitochondrial signaling in cell death via the Bcl-2 family. Cancer Biol Ther 2010;9:417–22
162. E.M.Sternberg Neural-immune interactions in health and disease. J Clin Invest 1997;100:2641–7
163. E.M.Reiche, S.O.Nunes, H.K.Morimoto Stress, depression, the immune system, and cancer. Lancet Oncol 2004;5:617–25
164. P.H.Thaker, A.K.Sood Neuroendocrine influences on cancer biology. Semin Cancer Biol 2008;18:164–70
165. H.O.Besedovsky, A.del Rey, I.Klusman,. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J Steroid Biochem Mol Biol 1991;40:613–18
166. A.S.Fauci Mechanisms of the immunosuppressive and anti-inflammatory effects of glucocorticosteroids. J Immunopharmacol 1978;1:1–25
167. K.E.Bethin, S.K.Vogt, L.J.Muglia Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci USA 2000;97:9317–22
168. M.H.Antoni, S.K.Lutgendorf, S.W.Cole,. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 2006;6:240–8
169. E.V.Yang, S.J.Kim, E.L.Donovan,. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun 2009;23:267–75
170. S.L.Valles, M.Benlloch, M.L.Rodriguez,. Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism. J Transl Med 2013;11:72
171. F.Marchesi, L.Piemonti, A.Mantovani, P.Allavena Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis. Cytokine Growth Factor Rev 2010;21:77–82
172. C.Yu, N.Yap, D.Chen, S.Cheng Modulation of hormone-dependent transcriptional activity of the glucocorticoid receptor by the tumor suppressor p53. Cancer Lett 1997;116:191–6
173. S.Sengupta, B.Wasylyk Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors. Ann NY Acad Sci 2004;1024:54–71
174. W.Hu, C.Zhang, R.Wu,. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci USA 2010;107:7455–60
175. Y.N.Zhao, X.Guo, Z.G.Ma,. Pro-apoptotic protein BIM in apoptosis of glucocorticoid-sensitive and -resistant acute lymphoblastic leukemia CEM cells. Med Oncol 2011;28:1609–17
176. D.Li, E.Ueta, T.Kimura,. Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination. Cancer Sci 2004;95:644–50
177. A.Ortega, P.Ferrer, J.Carretero,. Down-regulation of glutathione and Bcl-2 synthesis in mouse B16 melanoma cells avoids their survival during interaction with the vascular endothelium. J Biol Chem 2003;278:39591–9
178. S.Mena, M.L.Rodriguez, A.Ortega,. Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1. J Transl Med 2012;10:8
179. M.Bissell Q&A: Mina Bissell on tumors as organs. Cancer Discov 2013;3:7
180. M.J.Voss, F.Entschladen Tumor interactions with soluble factors and the nervous system. Cell Commun Signal 2010;8:21
181. T.Shibue, R.A.Weinberg Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment. Semin Cancer Biol 2011;21:99–106
182. J.K.Dethmers, A.Meister Glutathione export by human lymphoid cells: depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation. Proc Natl Acad Sci USA 1981;78:7492–6
183. R.Reliene, R.H.Schiestl Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice. Carcinogenesis 2006;27:240–4
184. P.W.Gout, A.R.Buckley, C.R.Simms, N.Bruchovsky Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug. Leukemia 2001;15:1633–40
185. K.Gumireddy, A.Li, L.Cao,. NOV-002, A glutathione disulfide mimetic, suppresses tumor cell invasion and metastasis. J Carcinog Mutagen 2013;2013:pii:S7-002
186. D.Trachootham, Y.Zhou, H.Zhang,. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 2006;10:241–52
187. M.Benlloch, S.Mena, P.Ferrer,. Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy. J Biol Chem 2006;281:69–79
188. K.J.Min, J.H.Jang, J.T.Lee,. Glucocorticoid receptor antagonist sensitizes TRAIL-induced apoptosis in renal carcinoma cells through up-regulation of DR5 and down-regulation of c-FLIP(L) and Bcl-2. J Mol Med (Berl) 2012;90:309–19
189. L.Raj, T.Ide, A.U.Gurkar,. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011;475:231–4
190. H.Steinbrenner, B.Speckmann, H.Sies Toward understanding success and failures in the use of selenium for cancer prevention. Antioxid Redox Signal 2013;19:181–91
191. S.Misra, M.Boylan, A.Selvam,. Redox-active selenium compounds – from toxicity and cell death to cancer treatment. Nutrients 2015;7:3536–56
192. K.El-Bayoumy, R.Sinha, J.P.Richie. Jr Forms of selenium in cancer prevention. In: R.Brigelius-Flohe, H.Sies, eds. Diversity of Selenium Functions in Health and Disease. Boca Raton (FL): CRC Press; 2015:137–55
193. Y.Cheng, U.H.Sk, Y.Zhang,. Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death. PLoS One 2012;7:e35104
194. P.Bapat, D.Goswami, A.Shastri,. A photographic comparison of seleno-trastuzumab, trastuzumab, and selenite on inhibition of the HER2+ human breast cancer cell line BT-474. Proceedings of the 10th International Symposium on Selenium in Biology and Medicine, Berlin, Germany 14–18 September 2013;p S15
195. M.Hidalgo, G.Rodriguez, J.G.Kuhn,. A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies. Clin Cancer Res 1998;4:2763–70
196. P.Jobanputra, R.Amarasena, F.Maggs,. Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: a case series from a local surveillance of serious adverse events. BMC Musculoskelet Disord 2008;9:48
197. C.Gorrini, I.S.Harris, T.W.Mak Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 2013;12:931–47
198. S.M.Redmond, F.Joncourt, K.Buser,. Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors. Cancer Res 1991;51:2092–7
199. S.J.Berger, D.Gosky, E.Zborowska,. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer. Cancer Res 1994;54:4077–83
200. M.Sprem, D.Babic, M.Abramic,. Glutathione and glutathione S-transferases as early markers for ovarian carcinomas: case series. Croat Med J 2001;42:624–9
201. E.Ferruzzi, R.Franceschini, G.Cazzolato,. Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neck. Eur J Cancer 2003;39:1019–29
202. J.A.Cook, H.I.Pass, S.N.Iype,. Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue. Cancer Res 1991;51:4287–94
203. R.R.Perry, J.A.Mazetta, M.Levin, S.C.Barranco Glutathione levels and variability in breast tumors and normal tissue. Cancer 1993;72:783–7
204. S.N.Hochwald, D.M.Rose, M.F.Brennan, M.E.Burt Elevation of glutathione and related enzyme activities in high-grade and metastatic extremity soft tissue sarcoma. Ann Surg Oncol 1997;4:303–9